Celularity Inc.

Celularity Inc.verified

CELU

Price:

$0.7129

Market Cap:

$17.15M

Celularity Inc. is a clinical-stage biotechnology enterprise dedicated to pioneering "off-the-shelf" allogeneic cell therapies, which are developed from placental sources. These innovative treatments are designed to combat a range of serious conditions, including various cancers, immune system dysfunctions, and infectious diseases. The company’s operations are segmented into three distinct areas: Cell Therapy, Degenerative Disease, and BioBanking. Their therapeutic pipeline features several key candidates: CYCART-19, a placental-derived CAR-T therapy, currently in Phase I trials for B-cell malignancies; CYNK-001, an unmodified natural killer (NK) cell also from placental sources, advancing t...[Read more]

Industry

Biotechnology

IPO Date

2019-08-08

Stock Exchange

NASDAQ

Ticker

CELU

The Enterprise Value as of June 2026 (TTM) for Celularity Inc. (CELU) is 51.87M

According to Celularity Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 51.87M. This represents a change of -49.50% compared to the average of 102.72M of the last 4 quarters.

Celularity Inc. (CELU) Historical Enterprise Value (quarterly & annually)

How has CELU Enterprise Value performed in the past?

The mean historical Enterprise Value of Celularity Inc. over the last ten years is 241.53M. The current 51.87M Enterprise Value has changed 2.05% with respect to the historical average. Over the past ten years (40 quarters), CELU's Enterprise Value was at its highest in in the March 2022 quarter at 1.12B. The Enterprise Value was at its lowest in in the December 2025 quarter at 63.14M.

Quarterly (TTM)
Annual

Average

241.53M

Median

205.52M

Minimum

63.14M

Maximum

645.47M

Celularity Inc. (CELU) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Celularity Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 260.75%

Maximum Annual Enterprise Value = 645.47M

Minimum Annual Increase = -64.04%

Minimum Annual Enterprise Value = 63.14M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
202563.14M-44.43%
2024113.63M4.07%
2023109.19M-52.96%
2022232.10M-64.04%
2021645.47M260.75%
2020178.93M-24.65%
2019237.47M-32.60%

Celularity Inc. (CELU) Average Enterprise Value

How has CELU Enterprise Value performed in the past?

The current Enterprise Value of Celularity Inc. (CELU) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

95.32M

5-year avg

232.71M

10-year avg

241.53M

Celularity Inc. (CELU) Enterprise Value vs. Peers

How is CELU’s Enterprise Value compared to its peers?

Celularity Inc.’s Enterprise Value is greater than BioAtla, Inc. (9.00M), greater than Reviva Pharmaceuticals Holdings, Inc. (-19627463.00), greater than Annovis Bio, Inc. (20.80M), greater than FibroGen, Inc. (11.12M), greater than Actinium Pharmaceuticals, Inc. (-8924256.00), less than BioXcel Therapeutics, Inc. (118.31M), greater than Kezar Life Sciences, Inc. (-11018667.00), greater than PolyPid Ltd. (40.34M), greater than Tempest Therapeutics, Inc. (11.64M), greater than Generation Bio Co. (40.14M),

Build a custom stock screener for Celularity Inc. (CELU) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Celularity Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Celularity Inc. (CELU) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Celularity Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Celularity Inc.'s Enterprise Value?

What is the highest Enterprise Value for Celularity Inc. (CELU)?

What is the 3-year average Enterprise Value for Celularity Inc. (CELU)?

What is the 5-year average Enterprise Value for Celularity Inc. (CELU)?

How does the current Enterprise Value for Celularity Inc. (CELU) compare to its historical average?